Data / Form D filings / CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd: Form D filing
CollPlant Biotechnologies Ltd, a health care company in Rehovot, Israel, filed a Form D with the SEC in 2026. The latest, on October 22, 2026, reports $9.2 million sold of a $9.2 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 OPPENHEIMER, WEIZMANN SCIENCE PARK, Rehovot, Israel, 76701
- Phone
- +972 73 232 5600
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1631487
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22 | New notice | $9,249,958 | $9,249,958 | 5 | Oct 9 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yehiel Tal | Executive Officer, Director | Chief Executive Officer and Interim Chairman of the Board of Directors |
| Eran Rotem | Executive Officer | Deputy Chief Executive Officer and Chief Financial Officer |
| Oren Fahimipoor | Executive Officer | Vice President, Operations |
| Philippe Bensimon | Executive Officer | Vice President, Regulatory Affairs and Quality Assurance |
| Jasmine Seror | Executive Officer | Vice President, Product Development |
| Bowman Bagley | Executive Officer | Vice President, Commercial North America |
| Bar Abelis | Executive Officer | Vice President, Legal |
| Ruti Ben Shlomi | Executive Officer, Director | Chief Executive Officer of Lightsolver Ltd., the Issuer's subsidiary. |
| Abraham Havron | Director | |
| Elan Penn | Director | |
| Joseph Zarzewsky | Director | |
| Hugh Evans | Director | |
| Alisa Lask | Director |
Every Form D from the week of Oct 19 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what CollPlant Biotechnologies Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.